Biogen Inc. (BIIB): A Bull Case Theory

We came across a bullish thesis on Biogen Inc. on r/Valueinvesting subreddit by U/Lobyous. In this article, we will summarize the bulls’ thesis on BIIB. Biogen Inc.'s share was trading at $131.52 as of July 25^th. BIIB’s trailing and forward P/E were 13.00 and 8.85 respectively according to Yahoo Finance.

[caption id="attachment_1236609" align="aligncenter" width="768"] A scientist in a lab, researching for a breakthrough treatment for Alzheimer's disease, diabetes nephropathy, asthma, COPD, NASH, and Type 1 Diabetes.[/caption]

Biogen (BIIB) remains deeply unloved by the market,...